INGHIRAMI, Giorgio
INGHIRAMI, Giorgio
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Analysis of the activating Kras mutations in advanced colorectal tumors: a three-year diagnostic experience
2011-01-01 Mariani, S.; Francia di celle, P.; Di Bello, C.; Bonello, L.; Toppino, D.; Tondat, F.; Barreca, A.; Molinaro, L.; Cassoni, P.; Chiusa, L.; Sapino, A.; Inghirami, G.
Anaplastic lymphoma Kinase: molecular mechanisms of lymphoid transformation
2006-01-01 Inghirami
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation
2005-01-01 Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells
2011-01-01 Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio
Core binding factor acute myeloid leukemia and c-kit mutations
2012-01-01 Pich A; Riera L; Frairia C; Toppino D; Audisio E; Sismondi F; D’Ardia S; Di Bello C; Messa E; Francia di Celle P; Marmont F; Inghirami G; Vitolo U
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients
2011-01-01 Sergio Occhipinti; Laura Sponton; Cristiana Caorsi; Augusto Amici; Cristina Marchini; Guido Forni; Anna Novarino; Michela Donadio; Libero Ciuffreda; Anna Sapino; Giorgio Inghirami; Francesco Novelli; Mirella Giovarelli
Dissection of Critical Pathways for Anaplastic Lymphoma Kinase Transformation
2007-01-01 Inghirami g
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation
2007-01-01 Piva R; E Pellegrino; V Grosso; AD Manazza; F Boccalatte; V Poli; A Neri; R Chiarle; G Inghirami
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity
2007-01-01 Piva R; Pellegrino E; Chiarle R; Manazza AD; Boccalatte F; Neri A; Levy DE; Inghirami G
Gene expression profiling uncovers molecular classifiers for the recognition of Anaplastic Large Cell Lymphoma within Peripheral T-cell neoplasms
2009-01-01 Piva R; Pellegrino E; Agnelli L; Neri A; Inghirami G
Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits
2008-01-01 Piva R, Pellegrino E, Agnelli L, Grosso V, Tamagno I, Ferrantino L, Cagnoni G, Fornari A; Novero D; Poli V, Zamò A, Chiosi M, Rosenwald A, Müller-Hermelink HK, Vermi W, Facchetti F, Fulciniti F, De Chiara A, Ponzoni M, Doglioni C, Piccaluga PP, Pileri S, De Wolf-Peeters C, Neri A, Inghirami G
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA
2005-01-01 R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami
Identification of molecular classifiers and key signalling networks in T-cell lymphoproliferative disorders through gene expression profiling meta-analyses
2011-01-01 Piva R; Limongi T; Agnelli L; Pellegrino E; Neri A; Iqbal J; Piccaluga PP; Pileri S; Kwee I; Bertoni F; Chen WC; Inghirami G
Molecular anatomy of peripheral T cell lymphomas
2009-01-01 Pellegrino E, Agnelli L, Todoerti K, Fornari A, Novero D; Cuccuru G, Ferreri C, Martinoglio B, Medico E, Zamò A, Facchetti F, De Chiara A, Ponzoni M, Rosenwald A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G, Piva R
Network-based inference of ALK oncogenic signaling in T-cell lymphoproliferative disorders
2010-01-01 Piva R; Pellegrino E; Agnelli L; Cantarella D; Ferreri C; Ferracin M; Cuccuru G; Voena C; Provero P; Negrini M; Di Cunto F; Neri A; Medico E; Inghirami G
Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders
2008-01-01 Piva R; Pellegrino E; Agnelli A; Tamagno I; Vallania F; Poli V; Medico E; Chatr-aryamontri A; Rosenwald A; Muller-Hermelink HK; Piccaluga PP; Pileri S; De Wolf-Peeters C; Neri A; Inghirami G
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells
2005-01-01 Piva R; Manazza A; Taulli R; Ponzetto C; Simmons W; Chiarle R; Inghirami G
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human Anaplastic Large Cell Lymphoma cells
2004-01-01 Piva R; Manazza AD; Taulli R; Ponzetto C; Chiarle R; Inghirami G
Targeting oncogenic ALK by stable small interfering RNA induces cell death of human Anaplastic Large Cell Lymphoma cells
2004-01-01 R Piva; A Manazza; R Taulli; C Ponzetto; R Chiarle; G Inghirami
The expression signature of Anaplastic Large Cell Lymphomas: from cell line to primary tumors
2008-01-01 Pellegrino E; Agnelli L; Grosso V; Tamagno I; Fornari A; Piccaluga PP; Pileri S; De Wolf-Peeters C; Neri A; Inghirami G; Piva R
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Analysis of the activating Kras mutations in advanced colorectal tumors: a three-year diagnostic experience | 2011 | Mariani, S.; Francia di celle, P.; Di Bello, C.; Bonello, L.; Toppino, D.; Tondat, F.; Barreca, A.; Molinaro, L.; Cassoni, P.; Chiusa, L.; Sapino, A.; Inghirami, G. | |
Anaplastic lymphoma Kinase: molecular mechanisms of lymphoid transformation | 2006 | Inghirami | |
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation | 2005 | Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G | |
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells | 2011 | Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio | |
Core binding factor acute myeloid leukemia and c-kit mutations | 2012 | Pich A; Riera L; Frairia C; Toppino D; Audisio E; Sismondi F; D’Ardia S; Di Bello C; Messa E; Francia di Celle P; Marmont F; Inghirami G; Vitolo U | |
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients | 2011 | Sergio Occhipinti; Laura Sponton; Cristiana Caorsi; Augusto Amici; Cristina Marchini; Guido Forni; Anna Novarino; Michela Donadio; Libero Ciuffreda; Anna Sapino; Giorgio Inghirami; Francesco Novelli; Mirella Giovarelli | |
Dissection of Critical Pathways for Anaplastic Lymphoma Kinase Transformation | 2007 | Inghirami g | |
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation | 2007 | Piva R; E Pellegrino; V Grosso; AD Manazza; F Boccalatte; V Poli; A Neri; R Chiarle; G Inghirami | |
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity | 2007 | Piva R; Pellegrino E; Chiarle R; Manazza AD; Boccalatte F; Neri A; Levy DE; Inghirami G | |
Gene expression profiling uncovers molecular classifiers for the recognition of Anaplastic Large Cell Lymphoma within Peripheral T-cell neoplasms | 2009 | Piva R; Pellegrino E; Agnelli L; Neri A; Inghirami G | |
Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits | 2008 | Piva R, Pellegrino E, Agnelli L, Grosso V, Tamagno I, Ferrantino L, Cagnoni G, Fornari A; Novero D; Poli V, Zamò A, Chiosi M, Rosenwald A, Müller-Hermelink HK, Vermi W, Facchetti F, Fulciniti F, De Chiara A, Ponzoni M, Doglioni C, Piccaluga PP, Pileri S, De Wolf-Peeters C, Neri A, Inghirami G | |
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA | 2005 | R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami | |
Identification of molecular classifiers and key signalling networks in T-cell lymphoproliferative disorders through gene expression profiling meta-analyses | 2011 | Piva R; Limongi T; Agnelli L; Pellegrino E; Neri A; Iqbal J; Piccaluga PP; Pileri S; Kwee I; Bertoni F; Chen WC; Inghirami G | |
Molecular anatomy of peripheral T cell lymphomas | 2009 | Pellegrino E, Agnelli L, Todoerti K, Fornari A, Novero D; Cuccuru G, Ferreri C, Martinoglio B, Medico E, Zamò A, Facchetti F, De Chiara A, Ponzoni M, Rosenwald A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G, Piva R | |
Network-based inference of ALK oncogenic signaling in T-cell lymphoproliferative disorders | 2010 | Piva R; Pellegrino E; Agnelli L; Cantarella D; Ferreri C; Ferracin M; Cuccuru G; Voena C; Provero P; Negrini M; Di Cunto F; Neri A; Medico E; Inghirami G | |
Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders | 2008 | Piva R; Pellegrino E; Agnelli A; Tamagno I; Vallania F; Poli V; Medico E; Chatr-aryamontri A; Rosenwald A; Muller-Hermelink HK; Piccaluga PP; Pileri S; De Wolf-Peeters C; Neri A; Inghirami G | |
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells | 2005 | Piva R; Manazza A; Taulli R; Ponzetto C; Simmons W; Chiarle R; Inghirami G | |
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human Anaplastic Large Cell Lymphoma cells | 2004 | Piva R; Manazza AD; Taulli R; Ponzetto C; Chiarle R; Inghirami G | |
Targeting oncogenic ALK by stable small interfering RNA induces cell death of human Anaplastic Large Cell Lymphoma cells | 2004 | R Piva; A Manazza; R Taulli; C Ponzetto; R Chiarle; G Inghirami | |
The expression signature of Anaplastic Large Cell Lymphomas: from cell line to primary tumors | 2008 | Pellegrino E; Agnelli L; Grosso V; Tamagno I; Fornari A; Piccaluga PP; Pileri S; De Wolf-Peeters C; Neri A; Inghirami G; Piva R |